Chiasma Inc. (CHMA)
3.76
-0.24 (-6.00%)
At close: Jan 01, 1970, 12:00 AM
-6.00% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 3.03M |
| Net Income (ttm) | -89.94M |
| EPS (ttm) | -1.573 |
| PE Ratio (ttm) | -2.390336935791481 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 8,196,718 |
| Avg. Volume (20D) | 996,380 |
| Open | 4.08 |
| Previous Close | 4.00 |
| Day's Range | 3.76 - 4.10 |
| 52-Week Range | 2.77 - 5.74 |
| Beta | 1.26 |
About CHMA
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess gro...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 16, 2015
Employees 84
Stock Exchange NASDAQ
Ticker Symbol CHMA
Website http://www.chiasma.com